- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Catheter Precision, Inc.: Historic Win for Electrophysiology Reimbursement in Ambulatory Surgery Centers Provides Unique Opportunity for Catheter Precision's LockeT Device | 790 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 25, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 21.11. | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.11. | Catheter Precision, Inc. - 8-K, Current Report | - | SEC Filings | ||
| CATHETER PRECISION Aktie jetzt für 0€ handeln | |||||
| 13.11. | Catheter Precision reports Q3 results | 1 | Seeking Alpha | ||
| 13.11. | Catheter Precision, Inc.: Catheter Precision (VTAK) Reports Third Quarter and First Nine Months 2025 Results of Operations | 632 | GlobeNewswire (Europe) | FORT MILL, S.C., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a U.S.-based innovative medical device company focused on the cardiac electrophysiology marketplace... ► Artikel lesen | |
| 13.11. | Catheter Precision, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 16.10. | Catheter Precision, Inc.: Catheter Precision Enters Distribution Agreement with FuMedica AG to Bring LockeT to Switzerland | 151 | GlobeNewswire (Europe) | FORT MILL, S.C., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company and a leading developer of innovative solutions for cardiac procedures... ► Artikel lesen | |
| 15.10. | Catheter Precision, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 30.09. | Catheter Precision, Inc. Announces Two New Patents to be Issued by USPTO | 142 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 30, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 10.09. | Catheter Precision, Inc.: Catheter Precision Announces Tender Win and First Purchase Order in Croatia | 1.099 | GlobeNewswire (Europe) | FORT MILL, S.C., Sept. 10, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device company focused on developing technologically advanced products for the... ► Artikel lesen | |
| 04.09. | Catheter Precision, Inc.: Catheter Precision Announces September 10th, 2025 Record Date for October 10th, 2025 Special Meeting of Stockholders | 1 | GlobeNewswire (USA) | ||
| 28.08. | Catheter Precision, Inc.: Catheter Precision Announces First Procedures in France as LockeT Expansion Continues | 1 | GlobeNewswire (USA) | ||
| 21.08. | Catheter Precision, Inc.: Catheter Precision Announces the Start of Enrollment for the LockeT Compare Study | 2 | GlobeNewswire (USA) | ||
| 18.08. | Catheter Precision, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 18.08. | Catheter Precision's LockeT Wound Closure Device Approved In UK; Shares Soar Over 65% | 1 | RTTNews | ||
| 15.08. | Catheter Precision executes 1-for-19 reverse stock split | 2 | Seeking Alpha | ||
| 15.08. | Catheter Precision, Inc. Announces Effectiveness of 1-for-19 Reverse Stock Split | 412 | GlobeNewswire (Europe) | FORT MILLS, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK), a US based medical device company focused on developing technologically advanced products for... ► Artikel lesen | |
| 15.08. | XFRA 4RM: AUSSETZUNG/SUSPENSION | 463 | Xetra Newsboard | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCATHETER PR. NEW... ► Artikel lesen | |
| 15.08. | XFRA NEW INSTRUMENTS AVAILABLE ON 15.08.2025 | 253 | Xetra Newsboard | The following instruments on XETRA do have their first trading 15.08.2025 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 15.08.2025
Aktien
1 US4560361028 Industrial Bank of Korea... ► Artikel lesen | |
| 14.08. | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 14.08.2025 | 574 | Xetra Newsboard | The following instruments on Boerse Frankfurt do have their last trading day on 14.08.2025.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 14.08.2025.ISIN NameCA87168M1068 SYNEX... ► Artikel lesen |
1 2 Weiter >>
40 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 47,360 | -0,06 % | Fresenius SE wackelt - dieser Boden sollte halten | Die Fresenius SE-Aktie steht kurz vor einer wichtigen Unterstützung. Hält der Bereich, oder droht ein Rückfall in tiefere Kursregionen Den vollständigen Artikel lesen ... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,140 | -0,19 % | FMC, Lanxess, Norma, Redcare Pharmacy, Suss MicroTec, TKMS - Aktien-Positionen der Short-Seller | Wer Aktien leerverkauft, also auf fallende Kurse spekuliert (Shortselling), unterliegt bestimmten Transparenzpflichten. Aktuelle Meldungen über Leerverkäufe geben Aufschluss darüber. Diese Vorgaben... ► Artikel lesen | |
| ECKERT & ZIEGLER | 16,180 | +0,75 % | Eckert&Ziegler-Aktie steht urplötzlich im Kreuzfeuer der Spekulanten - ungewöhnliche Aktivitäten sorgen für maximale Unruhe - clevere Anleger positionieren sich, bevor der Rest aufwacht. | ||
| BICO GROUP | 1,757 | +0,51 % | BICO Group AB: Publication of BICO Group AB: Interim report Q3 2025 | Organic sales growth in a continued soft market
Q3 2025 SummaryLife Science Solutions showed 4 percent organic sales growth YoY, which is in line with market performance. SCIENION continued to perform... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,095 | -3,57 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| RESMED | 221,20 | +0,55 % | Michael J Farrell Makes Strategic Play: Invests $179K In ResMed Stock Options | ||
| CARDINAL HEALTH | 183,95 | +0,30 % | Cardinal Health completes acquisition of Solaris Health | Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,684 | +1,63 % | Atossa Therapeutics Inc: Atossa Therapeutics Reports Third Quarter 2025 Financial Results and Provides a Corporate Update | Company reports progress to file planned IND for (Z)-endoxifen in mBC with CRO selection and streamlined development programs for potential 2026-NDA enabling activities... ► Artikel lesen | |
| UNIDOC HEALTH | 0,125 | +10,00 % | UniDoc erhält Bestellung für Health Cubes | - Die drei Einheiten sind für Demonstrationszwecke bei Verizon Innovation Labs
bestimmt
VANCOUVER, BC / 25. November 2025 / IRW-Press / UniDoc Health Corp. (CSE: UDOC) (FWB: L7T)... ► Artikel lesen | |
| ZIMMER BIOMET | 83,32 | -0,36 % | Zimmer Biomet Announces FDA Clearance For Enhanced Version Of ROSA Knee System | SEOUL (dpa-AFX) - Zimmer Biomet Holdings, Inc. (ZBH) announced FDA 510(k) clearance of ROSA Knee with OptimiZe, an enhanced version of its ROSA Knee System. Zimmer Biomet will conduct a targeted... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,480 | -100,00 % | Sonoma Pharmaceuticals, Inc.: National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced | BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
| CO-DIAGNOSTICS | 0,306 | -6,14 % | Maxim Group initiates coverage on Co-Diagnostics stock with Buy rating | ||
| VERU | 2,460 | +2,93 % | Veru Inc.: Veru Reports Fiscal 2025 Third Quarter Financial Results and Clinical Program Progress | --Company reported positive efficacy and safety data from Phase 2b QUALITY study showing enobosarm added to semaglutide led to preservation of muscle, greater fat loss, and fewer gastrointestinal... ► Artikel lesen | |
| CYTOSORBENTS | 0,678 | -0,59 % | Cytosorbents Corp: CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update | Third quarter 2025 revenue of $9.5 million, up 10% year-over-year
Amended credit agreement with Avenue Capital Group which strengthens our balance sheet... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics schließt Direktplatzierung über 4,25 Millionen US-Dollar ab |
Das Unternehmen CATHETER PRECISION INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 2,080 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CATHETER PRECISION INC finden Sie auf Wallstreet Online.